<VariationArchive VariationID="543053" VariationName="NC_000005.10:g.(?_37044327)_(37049321_?)del" VariationType="Deletion" Accession="VCV000543053" Version="7" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-17" DateCreated="2018-05-28" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="520593" VariationID="543053">
      <GeneList>
        <Gene Symbol="NIPBL" FullName="NIPBL cohesin loading factor" GeneID="25836" HGNC_ID="HGNC:28862" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5p13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="36876769" stop="37066413" display_start="36876769" display_stop="37066413" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="36876860" stop="37065920" display_start="36876860" display_stop="37065920" Strand="+" />
          </Location>
          <OMIM>608667</OMIM>
          <Haploinsufficiency last_evaluated="2020-08-26" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NIPBL">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-08-26" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NIPBL">Little evidence for dosage pathogenicity</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000005.10:g.(?_37044327)_(37049321_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>5p13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" innerStart="37044327" innerStop="37049321" display_start="37044327" display_stop="37049321" variantLength="4995" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" innerStart="37044429" innerStop="37049423" display_start="37044429" display_stop="37049423" variantLength="4995" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.(?_37044327)_(37049321_?)del" Assembly="GRCh38">
            <Expression>NC_000005.10:g.(?_37044327)_(37049321_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.(?_37044429)_(37049423_?)del" Assembly="GRCh37">
            <Expression>NC_000005.9:g.(?_37044429)_(37049423_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000005.10:g.(?_37044327)_(37049321_?)del AND Cornelia de Lange syndrome 1" Accession="RCV000653710" Version="7">
        <ClassifiedConditionList TraitSetID="548">
          <ClassifiedCondition DB="MedGen" ID="C4551851">Cornelia de Lange syndrome 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-10-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2017-10-16" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-05-28" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15591270</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16236812</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17106445</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20358602</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24635725</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26701315</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="548" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1016" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cornelia de Lange syndrome 1</ElementValue>
                <XRef ID="MONDO:0007387" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Brachmann de Lange syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Typus degenerativus amstelodamensis</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BDLS</ElementValue>
                <XRef Type="MIM" ID="122470" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">CDLS1</ElementValue>
                <XRef Type="MIM" ID="122470" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Cornelia de Lange syndrome (CdLS) encompasses a spectrum of findings from mild to severe. Severe (classic) CdLS is characterized by distinctive facial features, growth restriction (prenatal onset; &lt;5th centile throughout life), hypertrichosis, and upper-limb reduction defects that range from subtle phalangeal abnormalities to oligodactyly (missing digits). Craniofacial features include synophrys, highly arched and/or thick eyebrows, long eyelashes, short nasal bridge with anteverted nares, small widely spaced teeth, and microcephaly. Individuals with a milder phenotype have less severe growth, cognitive, and limb involvement, but often have facial features consistent with CdLS. Across the CdLS spectrum IQ ranges from below 30 to 102 (mean: 53). Many individuals demonstrate autistic and self-destructive tendencies. Other frequent findings include cardiac septal defects, gastrointestinal dysfunction, hearing loss, myopia, and cryptorchidism or hypoplastic genitalia.</Attribute>
                <XRef ID="NBK1104" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301283</ID>
                <ID Source="BookShelf">NBK1104</ID>
              </Citation>
              <XRef ID="199" DB="Orphanet" />
              <XRef ID="C4551851" DB="MedGen" />
              <XRef ID="MONDO:0007387" DB="MONDO" />
              <XRef Type="MIM" ID="122470" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1485361" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2018-05-28">
        <ClinVarSubmissionID localKey="NM_133433.3_5_Deletion (exons 35-40)|MedGen:CN029798" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000775596" DateUpdated="2024-06-09" DateCreated="2018-05-28" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-10-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17106445</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20358602</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15591270</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26701315</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24635725</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16236812</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Many different missense substitutions (p.Leu2144Phe, p.Thr2146Pro, p.Leu2150Pro, p.Tyr2216Ser, p.Asn2236Ile, p.Arg2298Ser) at codons within exons 35-40 have been classified as pathogenic (PMID: 17106445, 20358602, 15591270, 26701315, 24635725, 16236812). This suggests that these residues are critical for NIPBL protein function, and that deletion of this region is deleterious. Deletion of exons 35-40 has not been reported in the literature in individuals with a NIPBL-related disease. However, a smaller in-frame deletion of exons 37-39 has been observed in an individual with Cornelia de Lange Syndrome and determined to be Likely Pathogenic (Invitae database). This variant is an in-frame deletion of the genomic region encompassing exons 35-40 of the NIPBL gene. It preserves the integrity of the reading frame.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NIPBL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000005.9:g.(?_37044429)_(37049423_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN029798" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
          <SubmissionName>SUB3864685</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1485361" TraitType="Disease" MappingType="XRef" MappingValue="CN029798" MappingRef="MedGen">
        <MedGen CUI="C4551851" Name="Cornelia de Lange syndrome 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

